Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.

Arthritis Rheumatol · 2018 · PMC5947636 · PMID 29342499

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The analytical model for global disease activity showed a trend toward increased disease activity in patients who received CYC within the last 6 months, compared to patients who were never or not yet treated with CYC (Figure 2 B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.